Skip to main content

Day: March 11, 2026

Clearmind Medicine Advances Recruitment for CMND-100 Trial’s Third Cohort at Yale, Johns Hopkins and Tel Aviv Sites Following Recent Positive Topline Results

Vancouver, Canada, March 11, 2026 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on the discovery and development of novel, non-hallucinogenic, second generation, neuroplastogen-derived therapeutics to solve major under-treated health problems, today announced the continuation of participant enrollment for the third cohort of its ongoing FDA-approved Phase I/IIa clinical trial evaluating CMND-100, the Company’s proprietary non-hallucinogenic MEAI-based oral drug candidate, for the treatment of Alcohol Use Disorder (AUD). The recruitment follows the positive topline results recently reported from the second cohort, which demonstrated continued safety and tolerability, building on the favorable outcomes from prior cohorts. The Company’s...

Continue reading

Retirement Savers Who Max Out Catch-Up Contributions Can Still Fall $120,000 Short

PensionBee warns that late starters may need strategies beyond savings alone to minimize retirement shortfall NEW YORK, March 11, 2026 (GLOBE NEWSWIRE) — Americans who take full advantage of the IRS super catch-up provisions, which further expand 401(k) contribution limits for older Americans, may still retire $120,000 behind peers who started saving earlier, finds PensionBee. The analysis shows that a 50-year-old who maximizes 2026 catch-up and super catch-up limits could contribute over $505,500 out of pocket and still fall short of a $1 million nest egg by retirement. While catch-up and super catch-up limits may help those over 50 regain valuable ground, they alone cannot bridge the gap caused by a late start. Is 50 too late to start saving for retirement? PensionBee compared two retirement savers: one who began 401(k) contributions...

Continue reading

Callan JMB Inc. to Oversee Manufacturing and Quality Control of Attune Biotech’s IND Clinical Trials for lodonal™ in the Treatment of Long COVID

Callan JMB will Provide Independent Manufacturing Oversight and Governance as lodonal™ Undergoes Clinical Trials for Underserved Patient Population SPRING BRANCH, Texas, March 11, 2026 (GLOBE NEWSWIRE) — Callan JMB Inc. (NASDAQ: CJMB), (“Callan JMB” or the “Company”), an integrative logistics company empowering the healthcare industry and emergency management agencies through fulfillment, storage, monitoring, and cold chain logistics services, today announced that it has agreed with Biostax Corp d/b/a Attune Biotech Inc. (“Attune”), a clinical-stage biopharmaceutical company with a diversified therapeutic pipeline, to support its investigational new drug clinical trials for the treatment of Post-Acute Sequelae of SARS-CoV-2 infection (“PASC”), commonly known as Long COVID. The Company previously announced in January 2026,...

Continue reading

Actelis Networks Secures Japanese Governmental Order for Cyber-Hardened Networking Solutions for Critical Infrastructure

Order expands Actelis’ growing presence across Japan’s critical infrastructure sector, spanning civil and potentially military applications SUNNYVALE, Calif, March 11, 2026 (GLOBE NEWSWIRE) — Actelis Networks, Inc. (NASDAQ: ASNS) (“Actelis” or the “Company”), a market leader in cyber-hardened, rapid-deployment networking solutions for IoT and broadband applications, today announced it has received a significant order from a Japanese governmental entity for the supply of dozens of units of its MetaLight networking solutions to support critical civil and defense infrastructure modernization across Japan. The order, placed through Actelis’ established Japanese channel partner and distributor, will deploy dozens of the Company’s proven MetaLight units across a range of critical infrastructure...

Continue reading

John R. Wood Christie’s International Real Estate expands into Punta Gorda with acquisition of Walker Realty Group

Acquisition builds Charlotte County presence and enhances service for Southwest Florida buyers and sellers PUNTA GORDA, Fla., March 11, 2026 (GLOBE NEWSWIRE) — John R. Wood Christie’s International Real Estate, Southwest Florida’s leading real estate brokerage for the last five years*, is expanding its Southwest Florida footprint with the acquisition of Walker Realty Group, a respected Punta Gorda brokerage. The acquisition, which officially closed on February 27, 2026, marks a strategic step in the company’s continued growth across the region. Walker Realty Group brings a team of 11 agents, including founder Leanne Walker, who will remain with the firm. The Punta Gorda office, located at 110 Sullivan St., will be led by Roger Morris, a veteran Charlotte County broker with extensive local experience. “This marks an important step...

Continue reading

Cuprina Holdings Announces Key Regulatory Milestone in Saudi Arabia and Strengthens Global Scientific Advisory Board

SINGAPORE, March 11, 2026 (GLOBE NEWSWIRE) — Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) (“Cuprina” or “the Company”), a biomedical company developing and marketing products for the chronic wounds, infertility, medical waste recycling, and cosmeceuticals sectors, today  announced several strategic business developments, including a significant regulatory classification in Saudi Arabia and the expansion of its Medical and Scientific Advisory Board. Regulatory Milestone in Saudi Arabia Cuprina’s 49%-owned associate, Cuprina MENA Co. Ltd, has received official product classification from the Saudi Food and Drug Authority (SFDA) for MEDIFLY, the Company’s medical-grade maggot debridement therapy. The SFDA has classified MEDIFLY as a Medical Device–Drug combination product, with the primary mode of action regulated under the medical...

Continue reading

VisionWave Activates RF Sensing Layer of Its AI-Driven Autonomous Defense Platform Following Phase One Closing of SaverOne (NASDAQ: SVRE) Strategic Transaction – establishes VisionWave’s 19.99% ownership position in SaverOne

News Summary VisionWave Holdings Inc. (NASDAQ: VWAV) announced the completion of Phase One of its strategic transaction with SaverOne 2014 Ltd. (NASDAQ: SVRE), establishing VisionWave’s 19.99% ownership stake in SaverOne under the company’s previously announced definitive agreement dated January 26, 2026, and advances the path toward potential 51% ownership WEST HOLLYWOOD, Calif., March 11, 2026 (GLOBE NEWSWIRE) — VisionWave Holdings Inc. (NASDAQ: VWAV) today announced the completion of Phase One of its previously announced strategic transaction with SaverOne 2014 Ltd. (NASDAQ: SVRE). The Phase One closing occurred on March 5, 2026, establishing VisionWave’s initial ownership position of approximately 19.99% in SaverOne pursuant to the companies’ definitive agreement announced January 26, 2026. The agreement provides a framework...

Continue reading

ORAGENICS EXPLORES EXPANSION OF CNS PLATFORM PURSUING ACQUISTION OF ASSETS IN BRAIN HEALTH, RECOVERY, AND NEUROPROTECTION

SARASOTA, Fla., March 11, 2026 (GLOBE NEWSWIRE) — Oragenics, Inc. (NYSE American: OGEN), a clinical-stage biotechnology company pioneering brain-targeted therapeutics through proprietary intranasal delivery technology, today announced that it is exploring discussions with third parties regarding the potential acquisition of additional assets in the central nervous system (CNS) space, with a specific focus on brain health and brain recovery indications that demonstrate strategic synergies with the Company’s lead candidate ONP-002 and its proprietary intranasal drug delivery platform. The Company’s portfolio expansion initiative is being pursued independently of its existing partnership with Receptor.AI, which focuses on artificial intelligence-enabled CNS drug discovery. Together, these two parallel strategies — traditional...

Continue reading

Gaia Announces March Investor Conference Schedule

BOULDER, Colo., March 11, 2026 (GLOBE NEWSWIRE) — Gaia, Inc. (NASDAQ: GAIA), a conscious media and community company, will participate in the following upcoming investor events:Sidoti Small-Cap Virtual ConferenceDate: Wednesday, March 18th – Thursday, March 19th, 2026Location: Virtual38th Annual ROTH ConferenceDate: Sunday, March 22nd – Tuesday, March 24th, 2026Location: Dana Point, CaliforniaFor additional information about the events or to schedule a one-on-one meeting with Gaia, please contact GAIA@gateway-grp.com. About Gaia Gaia is a member-supported global video streaming service and community that produces and curates conscious media through four primary channels — Seeking Truth, Transformation, Alternative Healing, and Yoga — in four languages (English, Spanish, French, and German) to its members in 185 countries....

Continue reading

Navitas Adds Top-Side Cooled QDPAK and Low-Profile TO-247-4L to its Package Line-Up in the Latest 5th Generation GeneSiC™ Technology

QDPAK and Low-profile TO247 in the latest GeneSiC™ 5th Generation Trench-Assisted Planar SiC MOSFET technology deliver significant improvements in performance and lifetime for AI data centers, grid and energy infrastructure, and industrial electrification with voltage ratings of 1200 VNavitas Adds Top-Side Cooled QDPAK and Low-Profile TO-247-4L to its Package Line-Up in the Latest 5th Generation GeneSiC™ TechnologyQDPAK and Low-profile TO247 in the latest GeneSiC™ 5th Generation Trench-Assisted Planar SiC MOSFET technology deliver significant improvements in performance and lifetime for AI data centers, grid and energy infrastructure, and industrial electrification with voltageTORRANCE, Calif., March 11, 2026 (GLOBE NEWSWIRE) — Navitas Semiconductor (Nasdaq: NVTS), an industry leader in next-generation...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.